Alnylam Pharmaceuticals Inc. | Key People and Executives
John M. Maraganore
Chief Executive Officer & Director
Colleen F. Reitan
Director
Michael W. Bonney
Chairman
David E. I. Pyott
Independent Director
John K. Clarke
Independent Director
Marsha H. Fanucci
Independent Director
Paul R. Schimmel
Independent Director
Amy W. Schulman
Independent Director
Steven Marc Paul
Independent Director
Phillip A. Sharp
Independent Director
Dennis Arthur Ausiello
Independent Director
Barry E. Greene
President
John M. Maraganore
Chief Executive Officer & Director
Yvonne L. Greenstreet
Chief Operating Officer & Executive Vice President
Manmeet Singh Soni
Chief Financial Officer & Senior Vice President
Jing L. Marantz
Head-Medical Affairs & Senior Vice President
Al Boyle
Senior Vice President-Technical Operations
James P. Bilotta
Vice President-Information Technology
Jared A. Gollob
Vice President-Clinical Research
Akshay K. Vaishnaw
Executive Vice President-Research & Development
Eric Green
VP & General Manager-TTR Program
Vasant Jadhav
Senior Director-Research
Masako Nakamura
Senior Vice President & Head-Asia Region
Jae B. Kim
Vice President-Clinical Development
Akin Akinc
Vice President & General Manager-Fitusiran
Emmanuel Dulac
Chief Commercial Officer
Pushkal Garg
Chief Medical Officer
Maja Janas
Senior Scientist-Investigative Toxicology
Mark Schlegel
Senior Scientist
Theresa Heggie
Senior Vice President, Head-Europe & Canada Region
Peter F. Smith
Senior Vice President-Early Development
Nereyda Garcia
Global Head-Ethics & Compliance
Steven A. Bossone
Vice President-Intellectual Property
Mary Beth DeLena
Vice President & Associate General Counsel
Muthiah Manoharan
Senior Vice President-Drug Discovery
Aria Tavana
Vice President-Quality Assurance
Lubomir Nechev
Vice President-Process Sciences
Saraswathy V. Nochur
Senior Vice President-Regulatory Affairs
Colleen F. Reitan
Director
Michael P. Mason
Treasurer, CAO & VP-President
Joshua Brodsky
Associate Director-Investor Relations
Christine Regan Lindenboom
VP-Investor Relations & Corporate Communications
Karen M. Anderson
Chief Human Resources Officer & Senior VP
Laurie Bartlett Keating
Secretary, Senior Vice President & General Counsel
Alan F. Eisenberg
VP-Global Public Policy & Government Relations
Michael W. Bonney
Chairman
David E. I. Pyott
Independent Director
John K. Clarke
Independent Director
Marsha H. Fanucci
Independent Director
Paul R. Schimmel
Independent Director
Amy W. Schulman
Independent Director
Steven Marc Paul
Independent Director
Phillip A. Sharp
Independent Director
Dennis Arthur Ausiello
Independent Director
| Address |
300 Third Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.alnylam.com |
| Updated |
07/08/2019 |
| Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. |
